ArticleJAMA network open2024

Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer.

Meghan J Mooradian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.